Similar Articles
1281 Diabetes mellitus and metformin in hepatocellular carcinoma
1282 Hepatocellular carcinoma: Will novel targeted drugs really impact the next future?
1283 Alpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinoma
1284 Serum metabolome profiles characterized by patients with hepatocellular carcinoma associated with hepatitis B and C
1285 Immunohistochemistry panel segregates molecular types of hepatocellular carcinoma in Brazilian autopsy cases
1286 Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation
1287 Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma
1288 Transarterial radioembolization vs chemoembolization for hepatocarcinoma patients: A systematic review and meta-analysis
1289 Efficacy, safety, and dose comparison of degarelix for the treatment of prostate cancer: A systematic review and meta-analysis
1290 Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA